Avid Bioservices Inc (CDMO)

[keep_trying]

Loof, my targets are figuring that PPHM the stock reaches a market capitalization of $7 billion to $11 billion in conjunction with Bavi pending Phase 3 trial success and related PPHM buyout timing. The $100 billion market capitalization I view as reasonable enough to recognize Bavi, anti-PS family value, but I am presuming that this ten fold market cap enhancement posts on the books of the acquiring large Pharma. Of course, if PPHM is compelled to go it alone, it will take longer, but the higher market cap would prospectively post for PPHM share holders. Why? I am just speculating about what a Pharma partner candidate may want to stage for entry. A 10x upside is still good incentive and PPHM demonstrating success is imminent reduces risk.

Best wishes and IMO,
KT